Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30045
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNiaz, Aram-
dc.contributor.authorTruong, Jia Quyen-
dc.contributor.authorManoleras, Annabel-
dc.contributor.authorFox, Lucy-
dc.contributor.authorBlombery, Piers-
dc.contributor.authorVasireddy, Raja S-
dc.contributor.authorPickett, Hilda A-
dc.contributor.authorCurtin, Julie A-
dc.contributor.authorBarbaro, Pasquale M-
dc.contributor.authorRodgers, Jonathan-
dc.contributor.authorRoy, John-
dc.contributor.authorRiley, Lisa G-
dc.contributor.authorHolien, Jessica K-
dc.contributor.authorCohen, Scott B-
dc.contributor.authorBryan, Tracy-
dc.date2022-
dc.date.accessioned2022-06-22T06:51:12Z-
dc.date.available2022-06-22T06:51:12Z-
dc.date.issued2022-06-28-
dc.identifier.citationBlood Advances 2022; 6(12): 3779-3791.en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30045-
dc.description.abstractTelomere biology disorders (TBDs) are a spectrum of multisystem inherited disorders characterized by bone marrow failure, resulting from mutations in genes encoding telomerase or other proteins involved in maintaining telomere length and integrity. Pathogenicity of variants in these genes can be hard to evaluate, since TBD mutations show highly variable penetrance and genetic anticipation due to inheritance of shorter telomeres with each generation. Thus, detailed functional analysis of newly identified variants is often essential. Here we describe a patient with compound heterozygous variants in the TERT gene, which encodes the catalytic subunit of telomerase, hTERT; this patient has the extremely severe Hoyeraal-Hreidarsson form of TBD, although his heterozygous parents are clinically unaffected. Molecular dynamic modeling and detailed biochemical analyses demonstrate that 1 allele (L557P) affects association of hTERT with its cognate RNA component hTR, while the other (K1050E) affects the binding of telomerase to its DNA substrate and enzyme processivity. Unexpectedly, the data demonstrate a functional interaction between the proteins encoded by the 2 alleles, with WT hTERT able to rescue the effect of K1050E on processivity, whereas L557P hTERT cannot. These data contribute to the mechanistic understanding of telomerase, indicating that RNA binding in 1 hTERT molecule affects the processivity of telomere addition by the other molecule. This work emphasizes the importance of functional characterization of TERT variants to reach a definitive molecular diagnosis for TBD patients, and in particular it illustrates the importance of analyzing the effects of compound heterozygous variants in combination to reveal interallelic effects.en
dc.language.isoeng
dc.titleFunctional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder.en
dc.typeJournal Articleen
dc.identifier.journaltitleBlood Advancesen
dc.identifier.affiliationRare Diseases Functional Genomics, Kids Research, The Children's Hospital at Westmead and Children's Medical Research Institute, Westmead, NSW, Australia..en
dc.identifier.affiliationSchool of Science, STEM (Science, Technology, Engineering, and Mathematics) College, Royal Melbourne Institute of Technology (RMIT), Bundoora, VIC, Australia..en
dc.identifier.affiliationChildren's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia..en
dc.identifier.affiliationDepartment of Pathology, Peter MacCallum Cancer Center, Melbourne, VIC, Australia..en
dc.identifier.affiliationClinical Haematologyen
dc.identifier.affiliationTransfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia..en
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, VIC, Australia..en
dc.identifier.affiliationClinical Haematology, Peter MacCallum Cancer Center/Royal Melbourne Hospital, Melbourne, VIC, Australia..en
dc.identifier.affiliationHaematology Department, Children's Hospital at Westmead, Westmead, NSW, Australia..en
dc.identifier.affiliationChildren's Health Queensland and University of Queensland, South Brisbane, QLD, Australia..en
dc.identifier.affiliationGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.en
dc.identifier.affiliationChild and Adolescent Health, University of Sydney, Sydney, NSW, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35477117/en
dc.identifier.doi10.1182/bloodadvances.2022007029en
dc.type.contentTexten
dc.identifier.orcid0000-0001-6636-2555en
dc.identifier.orcid0000-0002-7328-189Xen
dc.identifier.orcid0000-0003-2849-4981en
dc.identifier.orcid0000-0002-9840-4841en
dc.identifier.orcid0000-0002-8735-2871en
dc.identifier.orcid0000-0002-7990-5501en
dc.identifier.orcid0000-0002-3855-8232en
dc.identifier.pubmedid35477117
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.